Enviro Tech Chemical Services, Inc. is a specialty chemical manufacturer founded in 1991 with headquarters in Modesto, California. In December 2021, the company was acquired by Arxada AG, a global specialty chemicals firm owned by private equity funds Bain Capital and Cinven. Following the acquisition, Enviro Tech operates as a subsidiary and business line within Arxada's Microbial Control Solutions division. Public information on its precise size is limited, but employee counts appear to be in the range of 100-500 people.
Enviro Tech develops and manufactures antimicrobial and biocidal products, with a focus on proprietary peracetic acid (PAA) and stabilized bromine formulations. Its EPA- and FDA-approved products are used for disinfection and to ensure safety in a variety of industries, including meat and poultry processing, food and beverage, industrial water treatment, agriculture, animal health, and oil and gas. The company holds a significant intellectual property portfolio, including dozens of EPA registrations and FDA Food Contact Notifications for its chemistries. Enviro Tech operates manufacturing facilities in Modesto, California; Helena, Arkansas; and Levelland, Texas.
Based on its litigation history, Enviro Tech is an operating company engaged in disputes with a competitor. The company's two tracked cases show it as both a plaintiff in federal court and a defendant in a patent office proceeding, a common posture for active competitors. The case data shows one suit filed by Enviro Tech as plaintiff in the U.S. District Court for the Western District of Texas and one administrative challenge where it is the defendant before the Patent Trial and Appeal Board.
The most notable recent event for the company is its 2021 acquisition by Arxada, which expanded Arxada's portfolio into the food and beverage hygiene market. The tracked patent litigation involves a direct competitor, Clean Chemistry, Inc. Enviro Tech filed an infringement suit against Clean Chemistry in late 2024, and Clean Chemistry subsequently challenged the patent's validity at the U.S. Patent and Trademark Office in 2025. This head-to-head legal conflict is indicative of a dispute over technology and market share.